Navigation Links
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Date:9/21/2007

by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products, including the results of any clinical programs with respect to TREANDA or the timing or acceptance of any current or future filings for regulatory approval of TREANDA or other Cephalon Oncology compounds; interpretation of clinical results, particularly with respect to the TREANDA clinical trials; manufacturing development and capabilities; market prospects for its products; sales and earnings guidance; and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. A Versatile Power Supply for All Electrophoresis Applications
2. Highest Possible Transformation Efficiencies for High-Throughput Applications
3. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
4. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
5. An Assessment of the Eppendorf twin.tec plate performance in PCR* applications
6. Principles and applications of electrical cell fusion
7. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
8. Optimizing Büchi® Rotary Evaporator Applications
9. Principles and applications of electrical cell fusion
10. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
11. Optimizing Büchi® Rotary Evaporator Applications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...new generation of ultrasmall transistors and more ...ed semiconducting nanowires are closer to reality ...e University and the University of California at L...o create nanowires with layers of different materi...which is a critical requirement for making efficie...
(Date:11/25/2009)...5 /PRNewswire/ - Cytochroma today announced the ap...ctors. Dr. Moldt will replace Mr. Ulrik Spork as t... The number of Board members remains unchanged at ... Peter Moldt to the board and look forward to bene...oma continues to make progress in becoming a leadi...
(Date:11/24/2009)...4 IES (Nasdaq: IESC ), ...unications systems and services for the commercial...day that its commercial business group has been aw...ll the electrical systems for the Level 4 bio-safe...my Medical Research Institute of Infectious Diseas...
(Date:11/24/2009)...YKJAVIK, Iceland, November 24 /PRNewswire-FirstCal...announced that it has received notice from,the Nas...mon stock will be,suspended as of November 30, 200...ies and Exchange Commission, which will remove deC...the company files an appeal to the Nasdaq,Listing ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...enter for Molecular,Medicine (CMM) today said it w...nursing mothers for codeine risks cited in a Frida... (FDA). Late Friday, the FDA issued an advisory n...us, side effect in nursing infants whose mothers a...izers of that drug. The FDA,advisory recommended p...
...is, Inc.,(NASDAQ: ISOT ) ("IsoTis"), an orthobiol...letter dated August 15, 2007 from the US Food and ...amily of Products for,marketing in the US as Class...s includes Accell 100, Accell Connexus and,Accell ... that is not,currently marketed. The products are ...
...Join Forces to Promote Early Detection ...YORK and MILTON KEYNES, United Kingdom, Aug. 20 ,I...d Omron Healthcare (UK),Ltd., a wholly owned subsi...eement to strengthen the link between hypertension... pharmacy healthcare markets. The,agreement combin...
Other Biology Technology:Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers 2IsoTis Receives FDA Clearance for Accell Family of Products 2IsoTis Receives FDA Clearance for Accell Family of Products 3IsoTis Receives FDA Clearance for Accell Family of Products 4InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 2InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 3InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 4
(Date:11/23/2009)...ociety says that western lowland gorillas living i...e "mother lode" of more than 125,000 gorillas disc...ed by growing humans activity in the region. , T...s adjacent to the southwest border of Lac Tl Commu...igh densities of the great apes still exist in the...
(Date:11/23/2009)...at a common oral bacterium may exacerbate autoimmu..."Unique Lipids from a Common Human Bacterium Repre...ing Autoimmunity," appears in the December 2009 is...ltiple sclerosis (MS), a disease where the immune ...nearly 1 in 700 people in the United States. Pati...
(Date:11/23/2009)...ble for the H1N1 virus has been sent to vaccinate ...ion marks the first time vaccine has been sent to ...owa State University,s Hank Harris, professor of a...nd has been shipping preventive doses to swine pro...eks., The latest vaccines were shipped to a swin...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2New marker for Alzheimers discovered 57078 1Green tea component may help preserve stored platelets tissues 9919 1Green tea component may help preserve stored platelets tissues 9919 2Green tea component may help preserve stored platelets tissues 9919 3K States plant pathology head named fellow of Phytopathology Society 9917 1K States plant pathology head named fellow of Phytopathology Society 9917 2
...versity reveals that doctors treating life-threate...the wrong dosage of adrenaline (epinephrine) becau... in salt water in glass ampoules which are broken ...aline contained in the ampoule is usually expresse...t water) and a ratio (1 part drug for every 1000 p...
...or patients with hepatitis C, having a low blood p...d with advanced disease. This problem is compounde...r the disease can further reduce platelet numbers ...se patients the treatment they urgently need. Now,...Medicine finds that a new drug, eltrombopag, appea...
...Human Genome Project and other studies linking hum...mous amount of research producing powerful evidenc...ticist Daniel J. Fairbanks explores some of the ma...erson on the planet in RELICS OF EDEN: THE POWERFU...ooks, $24.95). , This book comes at a time when t...
Other Biology News:Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 3There is powerful evidence of evolution in human DNA 2
Rat IFN-gamma ELISpot Kit from R&D Systems
Chloramphenicol Acetyltransferase Fluorometric (TMR) Assay Kit, FAST CAT from Molecular Probes (Invitrogen)
Amino acid mixture excluding l-[U-14C]methionine from GE Healthcare, formerly Amersham Biosciences
MitoPT-25:MITOCHONDRIAL PERMEABILITY TRANSITION KIT from AbD Serotec
Biology Products: